LP Agreement Red Flags: 8 Clauses That Can Cost You Everything as a Private Fund Investor
LP Agreement Red Flags: 8 Clauses That Cost Investors Most limited partners sign their LPA and never read it again, until something goes wrong. Eight specific clause types, documented in SEC enforceme
TL;DR: Most limited partners sign their LPA and never read it again, until something goes wrong. Eight specific clause types, documented in SEC enforcement actions and Delaware court decisions, routinely transfer wealth and control from LPs to GPs in ways that ILPA's 2021 Industry Intelligence Report found affecting 48% of LP fund investments.
The ILPA Model LPA Project has been publishing red-flag clause guidance since 2019, and the numbers from their 2021 Industry Intelligence Report are stark: 48% of LPs reported contractually modified or reduced fiduciary duties in more than half of their fund investments over the prior twelve months. Only one in four of those LPs successfully restored those duties during negotiations. These are not rare carve-outs from rogue managers. They are standard practice.
I've spent years reviewing LPAs across venture, private equity, and real asset funds. The clauses below are not theoretical risks. They are the specific provisions that enabled $400 million in LP capital misappropriation, $515,000 in management fee overcharges on a $2.36 million settlement, and a GP removal attempt that failed in Delaware court despite serious LP grievances. Here is what to look for before you sign.
The 8 Red Flag Clauses at a Glance
The table below maps each clause type to its plain-language consequence for LPs. The sections that follow break down the mechanics and the documented enforcement record behind each one.
| # | Clause Type | What It Says | What It Means for You |
|---|---|---|---|
| 1 | Fiduciary Duty Waiver | GP's fiduciary duties are modified or disclaimed to the extent permitted by applicable law | GP can act in its own interest without LP remedy in most states |
| 2 | High-Threshold GP Removal | GP removal requires 66.7%–75% vote by LP capital commitments | Even egregious misconduct rarely reaches the removal bar |
| 3 | Clawback Without Escrow (Missing Condition C) | GP returns carry only if aggregate distributions fall below preferred return | GP retains excess carry on 8%–12% IRR funds with no repayment obligation |
| 4 | Toothless Key Man Provision | Investment period suspends if named principals spend less than "substantially all" time on fund | 90–180-day cure periods and vague triggers let GPs continue charging fees |
| 5 | Fee Calculation Ambiguity | Management fee based on "invested capital" or "committed capital" at GP discretion | Ambiguous language exploited to overcharge, as in SEC v. Insight Venture Management |
| 6 | Absent or Toothless LPAC | Conflict transactions subject to LPAC approval; committee never formed | GP self-deals without oversight, as in SEC v. Closed Loop Partners |
| 7 | Subscription Line Without Preferred Return Accrual | GP may draw credit facilities; preferred return accrues from capital call date | IRR inflated by average 6.1 percentage points while LP time-value is silently eroded |
| 8 | Broad Expense Allocation Without Cap | Fund bears "all expenses related to portfolio company activities" including GP travel and advisory fees | Fund-level expenses shift GP operating costs to LP capital accounts |
Clause 1: The Fiduciary Duty Waiver Hidden in Boilerplate
Delaware law, the governing statute for the overwhelming majority of PE and VC funds, allows the LPA to modify or eliminate fiduciary duties entirely under the Delaware Revised Uniform Limited Partnership Act Section 17-303. Most GPs use this latitude. The language appears deep in the general provisions section and reads as neutral statutory compliance. It is not.
When a GP's fiduciary duties are contractually reduced, your primary legal remedy for self-dealing or conflicts of interest disappears. You are left with whatever express consent requirements the LPA includes, which connects directly to Clauses 5 and 6. The ILPA 2021 report found that 48% of LPs faced these modifications in more than half their recent fund investments, and only 25% successfully pushed back. I've seen this clause kill LP protections in three deals I've reviewed, and in each case, the investors did not realize it was there until they tried to contest a fee or a related-party transaction.
What to demand: the LPA should expressly preserve the GP's duty of loyalty and duty of care, or at minimum include a conflicts policy with LP Advisory Committee veto rights over GP affiliate transactions.
Clause 2: GP Removal Thresholds That Are Built to Fail
The JER Hudson GP XXI LLC v. DLE Investors LP (Del. Ch. C.A. No. 2021-0478-MTZ, May 2022) decision is required reading for any LP negotiating removal rights. In that case, LPs attempted to remove the GP over what they characterized as serious governance failures. The Delaware Court of Chancery found the removal attempt invalid, not because the GP had done nothing wrong, but because the LPA's cause standard was not satisfied under the precise contractual language the GP had drafted.
Most LPAs set no-cause removal at 66.7% to 75% of LP capital commitments. For-cause thresholds are often set at the same level or higher, with "cause" defined so narrowly that it excludes performance failures, undisclosed conflicts, and even some categories of breach. By the time LPs with 66.7% of capital agree on anything, the damage is done and the legal fees are mounting.
The ILPA Model LPA recommends no-cause removal at a simple majority of LP interests, specifically 50.1%. If a GP refuses this threshold entirely, that refusal tells you something about how they expect the relationship to go.
Clause 3: The Clawback Gap — When "Condition C" Is Missing
The clawback framework in most PE LPAs operates on three conditions. Condition A: the LP fails to receive its preferred return. Condition B: the GP received more than its agreed carried interest percentage on realized deals. Condition C, the one almost no LPA includes, covers overpayments made during the catch-up period when a fund performs in the 8% to 12% IRR range.
According to Reinhart Boerner Van Deuren's analysis of GP clawback provisions, fewer than 10% of PE fund LPAs include a Condition C clawback. A GP can legally retain excess carried interest on a modestly performing fund, one that returns 10% IRR rather than the 8% preferred return, with no legal obligation to repay. On a $200 million fund, that gap can represent millions in carry that has no structural basis in LP economics.
The ILPA Model LPA addresses this by recommending a 30% carried interest escrow held until each LP has received return of full capital contribution plus preferred return. The majority of market LPAs contain no mandatory escrow. Clawback obligations are backed by unsecured GP promises and personal guarantees that frequently expire or become uncollectable at fund wind-down.
Clause 4: Key Man Provisions That Protect Nobody
A well-drafted key man clause suspends the investment period and stops new capital deployment the moment a named principal leaves. In practice, GP-drafted key man provisions contain three escape hatches that gut this protection.
First, the trigger is typically "substantially all business time," which courts have not defined and which GPs interpret to exclude board seats, advisory roles, and speaking engagements. Second, most provisions include a 90-to-180-day cure period during which the GP may name a replacement and resume activity. Third, they typically include automatic reinstatement rights once a replacement is named, regardless of whether that person has any track record relevant to the fund's strategy.
During the entire cure period, management fees continue to accrue. The ILPA 2021 Industry Intelligence Report explicitly warned LPs not to treat key person provisions as a substitute for preserved fiduciary duties. The two protections are meant to operate together, and most market LPAs strip one while leaving a weakened version of the other.
Clause 5: Fee Calculation Ambiguity and the Insight Enforcement Action
The SEC's June 2023 order against Insight Venture Management LLC (IA Release No. 6332) is the clearest documented example of what ambiguous fee calculation language costs LPs. The SEC found that Insight exploited LPA language around management fee calculations to overcharge LPs from August 2017 through April 2021. The settlement was $2.36 million, and the SEC identified $515,000 in specific fee overcharges attributable to the clause interpretation dispute.
The pattern is consistent: the LPA uses "invested capital" or "committed capital" without a precise definition, and the GP selects the interpretation that maximizes the fee base. When the fund is winding down, "invested capital" can be interpreted to exclude write-downs, keeping the fee base artificially high relative to actual portfolio value.
What to require: a precise fee calculation table as an exhibit to the LPA, not by reference to a defined term. The exhibit should specify the calculation as of each quarter-end, including how impairments are treated.
Clause 6: The LPAC That Never Formed — Closed Loop Partners
The SEC's September 2024 order against Closed Loop Partners LLC (IA Release No. 6712) documents a conflict that should be impossible under any functional LPA: the GP's own fund documents required LPAC approval for conflict transactions, but the GP never formed the LPAC. That gap enabled an undisclosed $5 million bridge loan from the fund to a GP affiliate at 24% interest, a transaction that LPs had no mechanism to review or block because the oversight body the LPA required simply did not exist.
Closed Loop managed approximately $492 million in AUM. The SEC's order confirms that even at institutional scale, LPAC formation is not automatic, and LP reliance on contractual consent rights means nothing if the committee never convenes. Per the Morgan Lewis VC/PE Funds Deskbook on LP Advisory Committees, LPAC members also face personal liability risk from approving self-dealing transactions without adequate disclosure.
Before closing, verify in writing that the LPAC has been formed, has met at least once, and that its membership and voting procedures are specified in the LPA rather than left to GP discretion.
Clause 7: Subscription Lines and the IRR That Is Not What It Looks Like
A 2019 study by Albertus and Denes from Carnegie Mellon's Tepper School, published through the UNC Kenan Institute, found that subscription lines of credit inflate reported IRR by an average of 6.1 percentage points while slightly reducing investment multiples. The mechanism: the GP draws on a bank credit line to fund investments, delays calling LP capital, and measures IRR from the capital call date rather than the date the credit facility was drawn.
The ILPA 2021 report found that 98% of funds in a 153-LPA Colmore dataset now include credit facility provisions, and that subscription line use had become the fourth-highest commercial priority concern for LPs, up from tenth in 2020. Most LPAs do not require preferred return accrual to begin from the date the credit line is drawn. The result is a systematic understatement of LP time-value costs that makes funds appear to outperform on IRR while delivering the same or lower cash-on-cash returns.
Ask for performance figures reported both with and without credit facility effects before you commit. If a GP cannot or will not provide disaggregated performance data, that is an answer about how they view LP information rights generally.
Clause 8: Expense Allocation Without a Cap and the Abraaj Warning
Broad expense allocation language, provisions that make the fund responsible for all expenses related to portfolio company activities including GP travel, affiliate advisory fees, and broken-deal costs, is where LP economics erode quietly. Unlike fee overcharges, expense allocation abuse often falls within the literal terms of the LPA. The GP is doing exactly what the document permits.
The SEC amended complaint against Abraaj Investment Management Limited and Arif Naqvi (SDNY No. 19-cv-3244-AJN, 2019) documented misappropriation of more than $400 million from Abraaj Private Equity Fund IV and the Abraaj Growth Markets Health Fund. The LPAC consent rights in those fund documents were circumvented through falsified financial statements and short-term loan recycling. It is an extreme case, but it illustrates how expense and cash-flow mismanagement can persist for years when LPA oversight mechanisms lack audit rights with teeth.
The LPA should include an annual independent audit of fund-level expenses, a cap on organizational and formation expenses charged to the fund, and a requirement that any expense charged by a GP affiliate be disclosed to the LPAC in advance. Per the Ebadat Law GP/LP negotiation guidance (Feb 2026), expense offset provisions requiring that broken-deal fees and monitoring fees reduce management fees dollar-for-dollar are now a standard LP ask that many GPs accept in competitive fundraising markets.
What You Can Actually Negotiate
The ILPA model documents exist because individual LPs have limited negotiating power against established GPs. Use them as a benchmark, not a demand list. Flag the clauses that deviate most from ILPA standards, particularly fiduciary duty waivers, removal thresholds above 50%, and missing clawback escrow, and treat GP responses as a data point about how they will handle disputes after you sign.
Three asks that many GPs accept without pushback: a most-favored-nation provision in side letters, annual LP reporting that includes credit facility usage and its effect on IRR, and LPAC formation as a condition to closing rather than a post-closing obligation. None requires a GP to give up economic rights. All give you information you would otherwise lack. If a GP declines all three, that refusal is itself informative.
Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.
Part of Guide
Looking for investors?
Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.
About the Author
Jeff Barnes, MBA